LMR Partners’s Argos Therapeutics ARGS Stock Holding History
Bought
Maintained
Sold
Other funds holding ARGS
LMR Partners's ARGS Position: Q3 2017 in Review
LMR Partners sold out of Argos Therapeutics (ARGS) in Q3 2017, closing a stake of 2,251 shares — an estimated $16K sold.
LMR Partners first reported a position in ARGS in Q2 2017 and held it in 1 quarter. The position peaked at $16K in Q2 2017. 29 funds tracked by Wall St. Rank hold ARGS as of Q3 2017.
- LMR Partners reported no remaining Argos Therapeutics position as of Q3 2017 after selling out during the quarter.
- LMR Partners sold 2,251 Argos Therapeutics shares in Q3 2017, an estimated $16K.
- LMR Partners first reported a position in Argos Therapeutics in Q2 2017 and held it in 1 quarter.
- LMR Partners's Argos Therapeutics position peaked at $16K in Q2 2017.
- 29 funds tracked by Wall St. Rank held Argos Therapeutics as of Q3 2017.
Based on LMR Partners's 13F filing for Q3 2017, filed 9 Nov 2017.